Abstract
Objective: We investigated whether there was a growth or morbidity response to zinc supplementation.
Design: The study was randomized, placebo-controlled, and double-blind.
Setting: Children were recruited at clinics in Kingston, Jamaica, and supplemented at home.
Subjects: Children selected were singletons aged 6–24 months, and stunted (<–2.0 s.d. length for age, NCHS references). They were stratified by sex and age and randomly assigned to receive zinc supplement (n=31) or placebo (n=30). Four children were excluded because of hospitalization; all others had all measurements. Adequately nourished children (n=24) were recruited from a well-baby clinic.
Interventions: The supplement provided 5 mg elemental zinc in a syrup daily for 12 weeks; the placebo comprised the syrup only.
Main outcome measures: Caretakers were interviewed to obtain social background data, number of clinic visits and hospitalizations. Anthropometric measurements were done on enrolment, and after 6 weeks, 12 weeks and 12 months. Children's health was determined by weekly questionnaire to caretakers of the undernourished groups during the supplementation period.
Results: The supplemented and placebo groups were similar on enrolment. The adequately nourished children were from significantly better socio-economic circumstances. Mean initial hair zinc content was 5.5±4.8μmol/g (supplemented group) and 6.7±12.1 μmol/g (placebo)(n.s.). Regression analyses showed that there were no significant effects of supplementation on length, height or head circumference, nor on the incidence of any morbidity symptom. Mean duration of the episodes was significantly shorter for skin rashes in the supple-mented group compared with the control group (ANCOVA, P=0.02), and longer for vomiting (P=0.02). The incidence of hospitalization was significantly greater in the control group (Fisher's exact test, P=0.02).
Conclusions: Zinc supplementation reduced the hospitalizations which probably reflect severity of morbidity, but did not improve growth.
Sponsorship: The study was funded by the Commonwealth Caribbean Medical Research Council and a Research and Publications Grant, University of the West Indies, Mona. Tropivite Vitamin Drops were donated by Federated Pharmaceutical Co. Ltd, Jamaica; and zinc sulphate donated by Lascelles Laboratories Ltd., Jamaica.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gardner, J., Witter, M. & Ramdath, D. Zinc supplementation: effects on the growth and morbidity of undernourished Jamaican children. Eur J Clin Nutr 52, 34–39 (1998). https://doi.org/10.1038/sj.ejcn.1600509
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1600509
Keywords
This article is cited by
-
Zinc Supplementation for Promoting Growth in Children Under 5 years of age in Low- and Middle-income Countries: A Systematic Review
Indian Pediatrics (2019)
-
Beneficial effects of zinc supplementation on head circumference of Nepalese infants and toddlers: a randomized controlled trial
European Journal of Clinical Nutrition (2012)
-
Role of Maternal Nutrition on Gestational Age and Birth Weight
National Academy Science Letters (2012)
-
What zinc supplementation does and does not achieve in diarrhea prevention: a systematic review and meta-analysis
BMC Infectious Diseases (2011)
-
Effect of preventive zinc supplementation on linear growth in children under 5 years of age in developing countries: a meta-analysis of studies for input to the lives saved tool
BMC Public Health (2011)